Biomerica, Inc. (BMRA)

NASDAQ: BMRA · USD

$1.70

-0.03 (-1.7%)· Recorded snapshot

Market cap	7.8M
Revenue (ttm)	4.3M
Net income (ttm)	-5M
EPS (ttm)	-$1.63
Shares out	4.6M
Volume	5,946.5
Beta	0.42

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.3M
Net income (ttm): -5M
EPS (ttm): -$1.63
Market cap: 7.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-113.8

P25 n/aP50 n/aP75 n/a

ROIC-59

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BMRA indicators

Market & fundamental data

Available fields

218

Groups with data

Currency

USD

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000073290
Company name	Biomerica, Inc.
Country	United States
Country code	US
CUSIP number	09061H406
Earnings date	2026-10-15
Earnings time	amc
Employees	50
Employees change	-4
Employees growth	-7.41%
Enterprise value	$7.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-08-31
First seen	2026-05-09
Fiscal year end	May
Founded	1971
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US09061H4065
Last 10-K release date	2026-08-31
Last earnings date	2026-10-15
Last refreshed	2026-11-04
Last stock split date	2025-04-21
Last stock split type	Reverse
Market cap	$7.8M
Market cap category	Nano-Cap
Next earnings date	2027-01-13
Options	No
Price	$1.70
Price currency	USD
Sector	Healthcare
SIC code	2835
Stock price date	2026-11-03
Symbol	BMRA
U.S. state	California
Website	https://www.biomerica.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-95.72%
EV/Sales	1.71x
FCF / EV yield	-53.36%
FCF yield	-50.59%
Industry forward P/E	20.34x
Industry P/E	39.98x
P/B ratio	2.14x
P/S ratio	1.8x
Price / tangible book value	2.27x
Sector forward P/E	24x
Sector P/E	49.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-125.15%
EBITDA margin	-123.49%
Gross margin	0.95%
Operating margin	-125.15%
Pretax margin	-114.87%
Profit margin	-115.47%
Profit per employee	$-100,180
Revenue per employee	$86,760
ROA	-45.47%
ROA (5Y)	-37.51%
ROCE	-103.73%
ROE	-113.8%
ROE (5Y)	-78.64%
ROIC	-59%
SBC / revenue	11%
Tax / revenue	0.6%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	3
Gross profit growth	-93.52%
Gross profit growth (Q)	-75.71%
Gross profit growth 3Y	-64.46%
Gross profit growth 5Y	-23.77%
Net income growth years	3
Revenue growth	-11.18%
Revenue growth (Q)	-8.33%
Revenue growth (QoQ)	44.57%
Revenue growth 10Y	-1.91%
Revenue growth 3Y	-7.13%
Revenue growth 5Y	-9.93%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	$72,000
EBIT	$-5.4M
EBITDA	$-5.4M
EPS	$-1.63
FCF per share	$-0.86
Financing cash flow	$3.6M
Free cash flow	$-4M
Free cash flow minus SBC	$-4.4M
Gross profit	$41,000
Income taxes	$26,000
Investing cash flow	$-1,000
Net borrowing	$500,000
Net cash flow	$-320,000
Net income	$-5M
Operating cash flow minus SBC	$-4.4M
Operating income	$-5.4M
Revenue	$4.3M
Stock-based compensation	$477,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-10.46
Book value per share	$0.79
Debt / equity	0.64
Long-term assets	$2.7M
Long-term liabilities	$1.6M
Net cash (debt)	$407,000
Net cash / market cap	5.21%
Net cash growth	-84.81%
Net debt / equity	-0.11
Piotroski F-Score	1
Property, plant and equipment	$1.9M
Shareholders' equity	$3.6M
Tangible book value	$3.4M
Tangible book value per share	$0.75
Total assets	$8.1M
Total cash	$2.7M
Total debt	$2.3M
Total liabilities	$4.4M
WACC	5.04%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.58
Current assets	$5.4M
Current liabilities	$2.8M
Current ratio	1.91
Inventory turnover	2.77
Net working capital	$579,000
Quick ratio	1.28
Working capital	$2.6M
Working capital turnover	1.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-26.67%
Dividend yield	0%
Shareholder yield	-26.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-91.5%
10Y return CAGR	-21.85%
10Y total return	-91.5%
150-day SMA	$1.99
15Y price change	-56.1%
15Y return CAGR	-5.34%
15Y total return	-56.1%
1D price change	-1.73%
1M price change	-20.63%
1M total return	-20.63%
1W price change	-0.58%
1W total return	-0.58%
1Y price change	-39.07%
1Y return CAGR	-39.09%
1Y total return	-39.07%
20-day SMA	$1.77
200-day SMA	$2.04
20Y price change	-54.79%
20Y return CAGR	-3.89%
20Y total return	-54.79%
3M price change	14.09%
3M total return	14.09%
3Y price change	-72.58%
3Y return CAGR	-35.02%
3Y total return	-72.58%
50-day SMA	$2.07
50-day SMA vs 200-day SMA	50over200
52-week high	$2.94
52-week high date	2026-01-07
52-week low	$1.45
52-week low date	2026-08-04
5Y price change	-95%
5Y return CAGR	-45.08%
5Y total return	-95%
6M price change	-22.37%
6M total return	-22.37%
After-hours change	0.01%
After-hours close	$1.70
After-hours price	$1.70
All-time high	$187.12
All-time high date	2020-03-19
All-time low	$1.36
All-time low date	2003-01-06
Average true range (ATR)	$0.11
Average volume	10.1K
Beta (1Y)	1.24
Beta (2Y)	2.09
Beta (5Y)	0.42
Change from 52-week high	-42.08%
Change from 52-week low	17.24%
Change from all-time high	-99.09%
Change from all-time low	25%
Change from open	-0.41%
Day's gap	-1.33%
Dollar volume	$10,109
High price	$1.75
Low price	$1.70
Monthly RSI	36.35
Open price	$1.71
Position in 52-week range	0%
Premarket change	-22.35%
Premarket close	$1.70
Premarket price	$1.32
Previous close	$1.73
Price vs 150-day SMA	-14.4%
Price vs 20-day SMA	-4.12%
Price vs 200-day SMA	-16.63%
Price vs 50-day SMA	-17.76%
Relative volume	0.59
RSI	36.19
Sharpe ratio	-0.65
Sharpe ratio (3Y)	-0.05
Sharpe ratio (5Y)	-0.24
Sortino ratio	-0.88
Sortino ratio (3Y)	-0.02
Sortino ratio (5Y)	-0.34
Volume	5.9K
Weekly RSI	41.64
YTD price change	-32.54%
YTD total return	-32.54%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4.2M
Float percentage	91.78%
Shares change (QoQ)	6.2%
Shares change (YoY)	26.67%
Shares held by insiders	8.22%
Shares held by institutions	12.73%
Shares outstanding	4.6M
Short % of float	0.25%
Short % of shares	0.23%
Short ratio	0.5 days

Deeper analysis on BMRA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BMRA report

Is a complete BMRA research report available?

No complete published report is available for Biomerica, Inc. (BMRA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Biomerica, Inc. (BMRA)

Price

Financial snapshot

Fair-value bridge

Latest news · BMRA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BMRA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BMRA

Frequently asked questions